Japan’s biomarker and companion diagnostics environment is undergoing significant transformation as regulatory frameworks mature and co-development approaches gain broader institutional backing.

Prices: USD 0.50 – USD 3399.00

Time: 8:00 am to 6:00 pm

Speakers: Shelley Shaw, Head of Oncology Marketing, Astellas Pharma, Takaharu Hino, Senior Director, Regulatory Strategy and Policy, Oncology, Regulatory Affairs Division, R and D, AstraZeneca and more

Venue details: Hyatt Regency Tokyo, Shinjuku City, Tokyo, 160-0023, Japan